Considering the clinical and genetic heterogeneity of PRPH2-related diseases, genetic testing represents a valuable tool for supporting the clinical and instrumental diagnosis of IRDs. This evidence concerns the gene PRPH2 and respiratory distress syndrome in premature infants.